Rising Advanced Wound Care Demand Is Slated to Reach A CAGR of 3.7% By 2032

Adoption of advanced wound care products to grow with the rising prevalence of chronic and surgical wounds, with a latest report by Fact.MR estimating revenues to expand at nearly 4% CAGR through 2021. Rising cases of type-1 diabetes and diabetic ulcers has leveraged the utilization of advanced wound care treatments and products. Hence, fostering the sales of advanced wound care market.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=S&rep_id=4822?PS

According to the study by Fact.MR, the advanced wound care market is poised to reach a value nearly US$ 15 Bn by 2030-end. Burgeoning cases of chronic diseases such as diabetes and cancer in regions like North America and Europe are prompting the healthcare professionals to invest more in advanced healthcare infrastructure and R&D activities. Therefore, bolstering the demand of advanced wound care market.

For instance, according to National Institute of Health in U.S., over 1.25 million burn cases and 6.5 million chronic skin ulcer cases were registered in 2020, that accounted for an estimated US$ 15 billion in U.S. health care costs for chronic wound treatments. Acknowledging this statistic, the advanced wound care market is expected to expand further in the upcoming years.

"Prominent manufacturing companies are launching their product in U.S. as the cases for chronic wounds are registered more in the region, accelerating the demand for advanced wound care products and prompting higher production," says a Fact.MR analyst.

𝗞𝗲𝘆 𝗧𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀

• North America and Europe to collectively dominate the market

• Wound cleansers and foam dressings continue to be most lucrative products

• East and South Asia to emerge as a potential market, backed by expanding manufacturing companies

• Hospitals to remain lucrative segment owing to the higher footfalls of the patients for chronic wound and high healthcare infrastructure

• US to emerge as a lucrative market while China to witness significant growth through 2030

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4822

𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝘄𝗼𝘂𝗻𝗱 𝗰𝗮𝗿𝗲 𝗠𝗮𝗿𝗸𝗲𝘁- 𝗣𝗿𝗼𝗺𝗶𝗻𝗲𝗻𝘁 𝗗𝗿𝗶𝘃𝗲𝗿𝘀

• High prevalence of chronic and surgical wounds has increased the usage of advanced wound care products, accelerating the demand

• Growing potential of developing economies and advanced healthcare infrastructure to create attractive opportunities for manufacturers
Advanced wound care Market- Key Restraints

• High cost of advanced wound care products and chronic wound treatments are likely to hinder sales

• Non-absorbent property of semi-permeable films dressing and risk of getting a skin infection likely to cause a restrain

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲

B. Braun Melsungen AG, Molnlycke Healthcare, ConvaTec Group PLC., Coloplast A/S, Johnson and Johnson, Medline Industries Inc., 3M, Essity AB (BSN Medical), and Smith & Nephew PLC are some of the key players profiled by Fact.MR. Leading players are inclined towards using key strategies such as acquisition for expanding the product portfolios for further expansion of their revenue.
For instance, in 2018, B. Braun Melsungen AG launched 1-Ounce Prontosan Wound Gel X, with microbial colonization resistance within the dressing that prevents skin infection and softens necrotic tissue. The launch was approved by FDA and was expected to generate new revenue prospects for the company.

Likewise, in November 2020, Sanara Medtech announced the launch of BIAKOS Antimicrobial wound gel as well as viral testing results for BIAKOS skin and wound cleanser, that provides 93% of bacterial reduction within one hour of application. The launch benefitted the organization across various regions.
More Valuable Insights on Advanced wound care Market

Fact.MR, in its new offering, presents an in-depth analysis on the global advanced wound care market. The study divulges essential insights on the Advanced wound care market on the basis of product (wound cleansers, honey dressings, antimicrobial gels, semi-permeable films dressing, skin protectants, alginate dressings, hydrocolloid dressings, foam dressings, and others), end-user (hospitals, ambulatory surgical centers, and specialty clinics), and key regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa (MEA)).

𝗚𝗲𝘁 𝗙𝘂𝗹𝗹 𝗔𝗰𝗰𝗲𝘀𝘀 𝗼𝗳 𝗖𝗼𝗺𝗽𝗹𝗲𝘁𝗲 𝗥𝗲𝗽𝗼𝗿𝘁:https://www.factmr.com/checkout/4822

Contact: 

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.